Aravax's Seed VC Round

Aravax raised a round of funding on November 24, 2015. Investors include Brandon Capital Partners.

Aravax is developing a novel therapy for the treatment of peanut allergy which is anticipated to enter phase I clinical trial in 2016.…

Articles about Aravax's Seed VC Round: